Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
finasteride, Quantity: 1 mg
Arrotex Pharmaceuticals Pty Ltd
Finasteride
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; docusate sodium; pregelatinised maize starch; sodium starch glycollate type A; titanium dioxide; hypromellose; hyprolose; purified talc; iron oxide yellow; iron oxide red
Oral
28, 30
(S4) Prescription Only Medicine
AUROBINDO FINASTERIDE is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. AUROBINDO FINASTERIDE is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.
Visual Identification: Brown colored, film coated, biconvex, octagonal shaped tablets, debossed with 'J' on side and '81' on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-04-30